Insider Trading History of Lampert Mark N

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lampert Mark N since 2016. This trader's CIK number is 1233840. At the time of last reporting, Lampert Mark N was the Officer of Essa Pharma Inc.. (stock ticker symbol EPIX). Also see all insider trading activities at Essa Pharma Inc..

Note that in the past LAMPERT MARK N also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Xoma Royalty Corp (XOMA) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 XOMA 0 $0 1,043,440 $27,626,506 0 $0
2023 XOMA 22,249 $420,734 0 $0 0 $0
2022 XOMA 137,260 $2,390,749 0 $0 0 $0
2020 XOMA 487,066 $10,247,353 0 $0 0 $0
2019 XOMA 401,108 $8,618,515 0 $0 0 $0
2018 XOMA 266,229 $3,829,129 0 $0 0 $0

Yearly summary of insider trading at Xenon Pharmaceuticals Inc. (XENE) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 XENE 551,180 $2,048,386 0 $0 0 $0

Yearly summary of insider trading at Infinity Pharmaceuticals, Inc. (INFI) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 INFI 0 $0 5,848,520 $24,207,024 0 $0
2018 INFI 8,102,849 $13,034,270 0 $0 0 $0
2017 INFI 1,604,425 $2,013,942 0 $0 0 $0
2016 INFI 1,598,716 $2,086,187 0 $0 0 $0

Yearly summary of insider trading at Merus N.v. (MRUS) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 MRUS 1,474,180 $34,389,455 3,318,736 $76,582,405 0 $0
2020 MRUS 2,610,767 $36,212,866 0 $0 0 $0

Yearly summary of insider trading at Palvella Therapeutics, Inc. (PIRS) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 PIRS 0 $0 50,000 $224,949 0 $0

Yearly summary of insider trading at Capstone Therapeutics Corp. (CAPS) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 CAPS 0 $0 4,341,586 $260,495 0 $0

Yearly summary of insider trading at Glycomimetics Inc (GLYC) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 GLYC 2,199,349 $5,858,199 0 $0 0 $0
2019 GLYC 1,668,746 $5,309,949 0 $0 0 $0

Yearly summary of insider trading at Rain Oncology Inc. (RAIN) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 RAIN 3,978,444 $26,635,387 0 $0 0 $0
2021 RAIN 1,380,116 $21,952,282 0 $0 0 $0

Yearly summary of insider trading at Immune Design Corp. (IMDZ) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 IMDZ 0 $0 902,000 $1,654,268 0 $0

Yearly summary of insider trading at Moonlake Immunotherapeutics (MLTX) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 MLTX 0 $0 2,000,000 $100,004,000 0 $0

Yearly summary of insider trading at Arqule Inc (ARQL) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ARQL 0 $0 5,567,893 $18,768,435 0 $0

Yearly summary of insider trading at Olema Pharmaceuticals, Inc. (OLMA) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 OLMA 1,505,932 $14,818,370 0 $0 0 $0
2022 OLMA 200,000 $807,000 0 $0 0 $0
2021 OLMA 739,675 $6,945,548 0 $0 0 $0
2020 OLMA 1,135,334 $21,571,346 0 $0 0 $0

Yearly summary of insider trading at Point Biopharma Global Inc. (PNT) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 PNT 0 $0 17,161,278 $213,657,911 0 $0

Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 RPTX 783,709 $2,821,352 0 $0 0 $0
2022 RPTX 3,404,080 $41,398,923 0 $0 0 $0

Yearly summary of insider trading at Eledon Pharmaceuticals, Inc. (ELDN) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ELDN 1,927,937 $0 0 $0 0 $0
2023 ELDN 1,978,932 $0 0 $0 0 $0

Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 KYMR 317,167 $13,955,348 0 $0 0 $0
2023 KYMR 414,105 $5,301,258 0 $0 0 $0
2022 KYMR 1,498,127 $38,718,066 0 $0 0 $0
2021 KYMR 544,166 $25,575,802 0 $0 0 $0

Yearly summary of insider trading at Five Prime Therapeutics, Inc. (FPRX) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 FPRX 1,085,422 $5,126,123 7,393,340 $149,249,354 0 $0
2019 FPRX 3,538,308 $13,307,688 0 $0 0 $0

Yearly summary of insider trading at Ideaya Biosciences, Inc. (IDYA) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 IDYA 0 $0 46,409 $835,362 0 $0
2020 IDYA 120,527 $1,722,685 0 $0 0 $0

Yearly summary of insider trading at Cullinan Therapeutics, Inc. (CGEM) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CGEM 2,137,296 $21,295,540 0 $0 0 $0

Yearly summary of insider trading at Essa Pharma Inc. (EPIX) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EPIX 0 $0 156 $292 0 $0

Yearly summary of insider trading at Cytokinetics Inc (CYTK) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 CYTK 0 $0 1,502,984 $24,681,309 0 $0
2019 CYTK 342,072 $3,229,093 0 $0 0 $0

Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 CNCE 0 $0 386,289 $4,134,837 0 $0
2017 CNCE 331,916 $5,256,885 1,282,856 $34,188,112 0 $0

Yearly summary of insider trading at Alpine Immune Sciences, Inc. (NVLS) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 NVLS 325,348 $747,453 0 $0 0 $0

Yearly summary of insider trading at Cti Biopharma Corp (CTIC) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CTIC 0 $0 8,500,000 $52,020,000 0 $0
2021 CTIC 2,000,000 $5,000,000 0 $0 0 $0
2018 CTIC 6,333,333 $18,999,999 0 $0 0 $0
2016 CTIC 1,001,327 $1,218,614 0 $0 0 $0

Yearly summary of insider trading at Third Harmonic Bio, Inc. (THRD) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 THRD 0 $0 1,000,000 $14,300,000 0 $0
2022 THRD 214,063 $879,584 0 $0 0 $0

Yearly summary of insider trading at Calithera Biosciences, Inc. (CALA) by Lampert Mark N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 CALA 0 $0 2,283,598 $13,701,588 0 $0
2019 CALA 2,716,927 $7,494,539 0 $0 0 $0


Insider trading activities at 26 companies by Lampert Mark N:

1. Xoma Royalty Corp (XOMA)

2. Xenon Pharmaceuticals Inc. (XENE)

3. Infinity Pharmaceuticals, Inc. (INFI)

4. Merus N.v. (MRUS)

5. Palvella Therapeutics, Inc. (PIRS)

6. Capstone Therapeutics Corp. (CAPS)

7. Glycomimetics Inc (GLYC)

8. Rain Oncology Inc. (RAIN)

9. Immune Design Corp. (IMDZ)

10. Moonlake Immunotherapeutics (MLTX)

11. Arqule Inc (ARQL)

12. Olema Pharmaceuticals, Inc. (OLMA)

13. Point Biopharma Global Inc. (PNT)

14. Repare Therapeutics Inc. (RPTX)

15. Eledon Pharmaceuticals, Inc. (ELDN)

16. Kymera Therapeutics, Inc. (KYMR)

17. Five Prime Therapeutics, Inc. (FPRX)

18. Ideaya Biosciences, Inc. (IDYA)

19. Cullinan Therapeutics, Inc. (CGEM)

20. Essa Pharma Inc. (EPIX)

21. Cytokinetics Inc (CYTK)

22. Concert Pharmaceuticals, Inc. (CNCE)

23. Alpine Immune Sciences, Inc. (NVLS)

24. Cti Biopharma Corp (CTIC)

25. Third Harmonic Bio, Inc. (THRD)

26. Calithera Biosciences, Inc. (CALA)

Table 1. Insider trading of Xoma Royalty Corp (XOMA) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-16 XOMA Sale 392,723 27.10 10,642,793
2025-01-24 XOMA Sale 650,717 26.10 16,983,713
2023-01-05 XOMA Buy 19,000 18.39 349,315
2023-01-06 XOMA Buy 3,249 21.98 71,419
2022-09-23 XOMA Buy 16,600 16.50 273,850
2022-09-26 XOMA Buy 6,360 16.83 107,051
2022-09-27 XOMA Buy 1,682 16.89 28,408
2022-09-16 XOMA Buy 24,293 17.89 434,528
2022-09-15 XOMA Buy 5,575 17.96 100,138
2022-09-14 XOMA Buy 26,441 17.25 456,054
2022-09-16 XOMA Buy 24,293 17.89 434,528
2022-09-15 XOMA Buy 5,575 17.96 100,138
2022-09-14 XOMA Buy 26,441 17.25 456,054
2020-12-11 XOMA Buy 200,000 25.00 5,000,000
2020-09-21 XOMA Buy 22,328 18.39 410,500
2020-09-22 XOMA Buy 11,951 18.45 220,448
2020-09-23 XOMA Buy 17,089 18.20 311,019
2020-09-04 XOMA Buy 7,737 18.77 145,231
2020-08-31 XOMA Buy 16,005 18.48 295,788
2020-08-28 XOMA Buy 2,044 19.17 39,187
2020-09-01 XOMA Buy 17,572 18.87 331,513
2020-08-25 XOMA Buy 5,687 19.75 112,289
2020-08-24 XOMA Buy 11,683 19.31 225,587
2020-08-21 XOMA Buy 10,805 19.32 208,774
2020-08-18 XOMA Buy 895 19.27 17,245
2020-08-19 XOMA Buy 3,496 19.70 68,878
2020-08-20 XOMA Buy 1,772 19.12 33,880
2020-08-14 XOMA Buy 21,922 18.69 409,809
2020-08-13 XOMA Buy 1,050 17.80 18,693
2020-08-12 XOMA Buy 4,050 17.34 70,235
2020-03-25 XOMA Buy 8,264 17.20 142,132
2020-03-18 XOMA Buy 4,439 14.53 64,476
2020-03-13 XOMA Buy 100,000 18.34 1,834,100
2020-03-16 XOMA Buy 10,164 15.73 159,920
2020-03-17 XOMA Buy 8,113 15.73 127,649
2019-12-19 XOMA Buy 373,195 22.00 8,210,290
2019-05-14 XOMA Buy 13,816 14.74 203,661
2019-05-13 XOMA Buy 3,797 14.36 54,524
2019-05-10 XOMA Buy 10,300 14.57 150,040
2018-12-17 XOMA Buy 25,000 14.19 354,800
2018-12-11 XOMA Buy 9,400 14.50 136,271
2018-12-12 XOMA Buy 2,810 14.75 41,447
2018-12-13 XOMA Buy 24,253 14.41 349,534
2018-12-06 XOMA Buy 10,927 14.80 161,697
2018-12-10 XOMA Buy 18,081 14.54 262,970
2018-12-07 XOMA Buy 32,015 14.77 472,765
2018-11-30 XOMA Buy 4,823 14.85 71,616
2018-12-03 XOMA Buy 806 14.90 12,009
2018-12-04 XOMA Buy 4,171 14.99 62,514
2018-11-29 XOMA Buy 10,016 14.93 149,538
2018-11-28 XOMA Buy 8,288 15.11 125,264
2018-11-27 XOMA Buy 11,396 15.24 173,675
2018-11-19 XOMA Buy 9,771 13.93 136,061
2018-11-20 XOMA Buy 37,482 13.68 512,716
2018-11-21 XOMA Buy 25,000 15.00 374,900
2018-11-15 XOMA Buy 21,141 13.31 281,365
2018-11-16 XOMA Buy 10,849 13.82 149,987

Table 2. Insider trading of Xenon Pharmaceuticals Inc. (XENE) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-08-15 XENE Buy 18,858 2.41 45,485
2017-08-14 XENE Buy 41,344 2.70 111,794
2017-06-27 XENE Buy 85,461 4.00 341,844
2017-06-22 XENE Buy 8,263 4.00 33,052
2017-06-21 XENE Buy 12,148 4.00 48,592
2017-06-15 XENE Buy 11,779 3.84 45,196
2017-06-16 XENE Buy 11,034 3.85 42,480
2017-06-19 XENE Buy 3,595 3.85 13,840
2017-06-06 XENE Buy 150,909 3.75 565,908
2017-06-07 XENE Buy 207,789 3.85 800,195

Table 3. Insider trading of Infinity Pharmaceuticals, Inc. (INFI) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-01-22 INFI Sale 5,848,520 4.14 24,207,024
2018-12-13 INFI Buy 175,000 1.20 210,000
2018-11-28 INFI Buy 100,000 1.30 130,000
2018-11-19 INFI Buy 1,465,126 1.36 1,992,571
2018-11-21 INFI Buy 4,700 1.35 6,345
2018-11-15 INFI Buy 91,474 1.35 123,489
2018-11-14 INFI Buy 210,250 1.34 281,735
2018-11-13 INFI Buy 604,208 1.35 815,680
2018-06-19 INFI Buy 3,516,560 1.65 5,802,324
2018-06-21 INFI Buy 425,531 1.65 702,126
2018-04-10 INFI Buy 1,010,000 2.00 2,020,000
2018-04-09 INFI Buy 500,000 1.90 950,000
2017-10-04 INFI Buy 653,449 1.28 839,028
2017-10-03 INFI Buy 946,597 1.24 1,169,047
2017-01-03 INFI Buy 4,379 1.34 5,867
2016-12-30 INFI Buy 3,553 1.34 4,761
2016-12-28 INFI Buy 738,848 1.34 987,100
2016-12-16 INFI Buy 434,656 1.28 556,359
2016-12-19 INFI Buy 198,264 1.36 269,242
2016-12-20 INFI Buy 22,001 1.35 29,811
2016-12-01 INFI Buy 148,894 1.19 176,439
2016-12-02 INFI Buy 52,500 1.19 62,475

Table 4. Insider trading of Merus N.v. (MRUS) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-10-07 MRUS Sale 985,447 27.53 27,130,341
2021-10-08 MRUS Sale 147,267 27.79 4,092,108
2021-07-02 MRUS Sale 2,186,022 20.75 45,359,956
2021-03-30 MRUS Buy 300,000 19.75 5,925,000
2021-03-22 MRUS Buy 79,500 22.75 1,808,625
2021-03-16 MRUS Buy 250,000 23.00 5,750,000
2021-01-21 MRUS Buy 844,680 24.75 20,905,830
2020-12-18 MRUS Buy 160,000 16.05 2,568,000
2020-09-15 MRUS Buy 146,754 11.75 1,724,359
2020-09-10 MRUS Buy 189,651 11.10 2,104,746
2020-09-03 MRUS Buy 201,906 11.17 2,255,290
2020-06-08 MRUS Buy 87,254 15.20 1,326,260
2020-06-01 MRUS Buy 1,462,510 14.00 20,475,140
2020-01-16 MRUS Buy 278,730 16.15 4,501,489
2020-01-13 MRUS Buy 83,962 14.98 1,257,582

Table 5. Insider trading of Palvella Therapeutics, Inc. (PIRS) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-09-06 PIRS Sale 50,000 4.50 224,949

Table 6. Insider trading of Capstone Therapeutics Corp. (CAPS) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-07-14 CAPS Sale 4,341,586 .06 260,495

Table 7. Insider trading of Glycomimetics Inc (GLYC) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-11-04 GLYC Buy 1,266,737 2.60 3,293,516
2020-10-30 GLYC Buy 932,612 2.75 2,564,683
2019-09-05 GLYC Buy 1,668,746 3.18 5,309,949

Table 8. Insider trading of Rain Oncology Inc. (RAIN) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-11-08 RAIN Buy 1,710,358 5.83 9,971,387
2022-11-08 RAIN Buy 1,710,358 5.83 9,971,387
2022-01-06 RAIN Buy 61,343 12.00 735,993
2022-01-07 RAIN Buy 496,385 12.00 5,956,620
2021-09-21 RAIN Buy 11,033 13.94 153,833
2021-09-13 RAIN Buy 392,269 16.49 6,468,515
2021-07-01 RAIN Buy 317,279 15.65 4,965,416
2021-07-06 RAIN Buy 269,723 15.25 4,113,275
2021-05-24 RAIN Buy 1,361 15.89 21,633
2021-05-21 RAIN Buy 121,986 15.94 1,944,700
2021-05-18 RAIN Buy 191,197 16.65 3,183,430
2021-05-19 RAIN Buy 17,268 15.88 274,284
2021-05-13 RAIN Buy 58,000 14.26 827,196

Table 9. Insider trading of Immune Design Corp. (IMDZ) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-04 IMDZ Sale 902,000 1.83 1,654,268

Table 10. Insider trading of Moonlake Immunotherapeutics (MLTX) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-10-04 MLTX Sale 2,000,000 50.00 100,004,000

Table 11. Insider trading of Arqule Inc (ARQL) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-05-30 ARQL Sale 1,035,939 5.00 5,179,695
2018-04-18 ARQL Sale 2,230,373 3.10 6,914,156
2018-04-04 ARQL Sale 2,301,581 2.90 6,674,584

Table 12. Insider trading of Olema Pharmaceuticals, Inc. (OLMA) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-12 OLMA Buy 1,505,932 9.84 14,818,370
2022-06-10 OLMA Buy 200,000 4.04 807,000
2021-11-30 OLMA Buy 739,675 9.39 6,945,548
2020-11-19 OLMA Buy 1,135,334 19.00 21,571,346

Table 13. Insider trading of Point Biopharma Global Inc. (PNT) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-12-18 PNT Sale 17,161,278 12.45 213,657,911

Table 14. Insider trading of Repare Therapeutics Inc. (RPTX) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-02 RPTX Buy 783,709 3.60 2,821,352
2022-06-13 RPTX Buy 149,161 12.73 1,898,819
2022-06-03 RPTX Buy 644,044 12.29 7,912,724
2022-06-06 RPTX Buy 6,869 13.21 90,753
2022-06-02 RPTX Buy 1,186,045 11.68 13,855,377
2022-05-18 RPTX Buy 420,000 8.50 3,570,000
2022-01-19 RPTX Buy 997,961 14.10 14,071,250

Table 15. Insider trading of Eledon Pharmaceuticals, Inc. (ELDN) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-05-09 ELDN Buy 1,927,937 .00 0
2023-05-05 ELDN Buy 1,978,932 .00 0

Table 16. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-30 KYMR Buy 317,167 44.00 13,955,348
2023-11-03 KYMR Buy 197,699 14.07 2,781,427
2023-11-02 KYMR Buy 216,406 11.64 2,519,831
2022-08-22 KYMR Buy 545,525 26.00 14,183,650
2022-05-26 KYMR Buy 224,057 14.21 3,184,074
2022-05-27 KYMR Buy 65,369 14.78 966,349
2022-05-20 KYMR Buy 10,100 14.00 141,389
2022-05-05 KYMR Buy 150,000 19.60 2,939,850
2022-05-06 KYMR Buy 100,000 19.25 1,925,500
2022-01-27 KYMR Buy 95,901 38.33 3,676,077
2022-01-31 KYMR Buy 34,408 40.70 1,400,405
2022-01-24 KYMR Buy 272,767 37.76 10,300,772
2021-07-01 KYMR Buy 544,166 47.00 25,575,802

Table 17. Insider trading of Five Prime Therapeutics, Inc. (FPRX) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-11-11 FPRX Sale 7,393,340 20.19 149,249,354
2020-11-04 FPRX Buy 416,562 4.88 2,034,488
2020-11-06 FPRX Buy 30,000 4.98 149,520
2020-10-06 FPRX Buy 345,241 5.04 1,738,288
2020-09-22 FPRX Buy 32 3.80 121
2020-05-14 FPRX Buy 293,587 4.10 1,203,706
2019-12-20 FPRX Buy 515,020 4.05 2,085,831
2019-12-09 FPRX Buy 135,000 4.02 542,430
2019-11-22 FPRX Buy 1,120,010 3.40 3,808,034
2019-11-05 FPRX Buy 968,112 4.00 3,872,448
2019-10-31 FPRX Buy 6,833 3.85 26,307
2019-10-29 FPRX Buy 2,400 3.90 9,352
2019-10-30 FPRX Buy 20,081 3.89 78,155
2019-10-24 FPRX Buy 135,388 3.75 507,028
2019-10-25 FPRX Buy 30,782 3.75 115,340
2019-10-23 FPRX Buy 3,200 3.75 11,987
2019-10-07 FPRX Buy 525,070 3.75 1,968,487
2019-10-08 FPRX Buy 60,412 3.68 222,497
2019-10-04 FPRX Buy 16,000 3.74 59,792

Table 18. Insider trading of Ideaya Biosciences, Inc. (IDYA) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-02 IDYA Sale 46,409 18.00 835,362
2020-06-30 IDYA Buy 2,531 13.32 33,702
2020-06-19 IDYA Buy 98,264 14.39 1,414,018
2020-06-22 IDYA Buy 19,732 13.94 274,965

Table 19. Insider trading of Cullinan Therapeutics, Inc. (CGEM) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-01 CGEM Buy 751,396 11.00 8,264,604
2022-05-12 CGEM Buy 1,000,000 9.06 9,060,000
2022-05-13 CGEM Buy 109,900 9.13 1,003,936
2022-04-01 CGEM Buy 276,000 10.75 2,967,000

Table 20. Insider trading of Essa Pharma Inc. (EPIX) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-05 EPIX Sale 156 1.88 292

Table 21. Insider trading of Cytokinetics Inc (CYTK) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-09 CYTK Sale 430,954 18.00 7,757,172
2020-02-13 CYTK Sale 1,072,030 15.79 16,924,137
2019-12-10 CYTK Buy 223,659 9.40 2,102,394
2019-12-11 CYTK Buy 118,413 9.52 1,126,699

Table 22. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-10 CNCE Sale 386,289 10.70 4,134,837
2017-12-19 CNCE Sale 1,282,856 26.65 34,188,112
2017-10-19 CNCE Buy 331,916 15.84 5,256,885

Table 23. Insider trading of Alpine Immune Sciences, Inc. (NVLS) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-06-20 NVLS Buy 17,806 2.25 40,063
2017-06-07 NVLS Buy 36,900 2.28 84,168
2017-06-05 NVLS Buy 35,750 2.29 81,903
2017-05-30 NVLS Buy 18,900 2.30 43,394
2017-05-31 NVLS Buy 28,100 2.25 63,140
2017-05-18 NVLS Buy 29,886 2.30 68,737
2017-05-17 NVLS Buy 37,372 2.30 85,918
2017-05-19 NVLS Buy 11,600 2.30 26,679
2017-05-09 NVLS Buy 40,000 2.29 91,519
2017-05-10 NVLS Buy 62,000 2.35 145,452
2017-05-11 NVLS Buy 7,034 2.34 16,480

Table 24. Insider trading of Cti Biopharma Corp (CTIC) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-08-09 CTIC Sale 8,500,000 6.12 52,020,000
2021-04-01 CTIC Buy 2,000,000 2.50 5,000,000
2018-02-09 CTIC Buy 6,333,333 3.00 18,999,999
2016-01-07 CTIC Buy 633,780 1.22 771,310
2016-01-08 CTIC Buy 367,547 1.22 447,304

Table 25. Insider trading of Third Harmonic Bio, Inc. (THRD) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-10-29 THRD Sale 1,000,000 14.30 14,300,000
2022-12-20 THRD Buy 214,063 4.11 879,584

Table 26. Insider trading of Calithera Biosciences, Inc. (CALA) by Lampert Mark N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-05-21 CALA Sale 2,283,598 6.00 13,701,588
2019-11-20 CALA Buy 191,954 3.91 750,924
2019-11-14 CALA Buy 128,488 3.37 433,004
2019-10-29 CALA Buy 1,598,977 2.60 4,157,340
2019-10-30 CALA Buy 797,508 2.70 2,153,271

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lampert Mark N (Officer of Essa Pharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.